PL436747A1 - Use of a 1,3-benzodioxole-5-sulfonyl quinazoline derivative in the manufacture of a drug with antineoplastic activity - Google Patents
Use of a 1,3-benzodioxole-5-sulfonyl quinazoline derivative in the manufacture of a drug with antineoplastic activityInfo
- Publication number
- PL436747A1 PL436747A1 PL436747A PL43674721A PL436747A1 PL 436747 A1 PL436747 A1 PL 436747A1 PL 436747 A PL436747 A PL 436747A PL 43674721 A PL43674721 A PL 43674721A PL 436747 A1 PL436747 A1 PL 436747A1
- Authority
- PL
- Poland
- Prior art keywords
- benzodioxole
- sulfonyl
- drug
- manufacture
- quinazoline derivative
- Prior art date
Links
- PERLPUYXHQGXST-UHFFFAOYSA-N O=S(C(C=C1)=CC2=C1OCO2)(C1=NC2=CC=CC=C2C=N1)=O Chemical class O=S(C(C=C1)=CC2=C1OCO2)(C1=NC2=CC=CC=C2C=N1)=O PERLPUYXHQGXST-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 230000000118 anti-neoplastic effect Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 201000009019 intestinal benign neoplasm Diseases 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest zastosowanie 1,3-benzodioksolo-5-sulfonylowej pochodnej chinazoliny przedstawionej wzorem 1 do wytwarzania leku o działaniu przeciwnowotworowym, zwłaszcza wobec białaczek, nowotworów jelit lub mózgu.The present invention relates to the use of a 1,3-benzodioxole-5-sulfonyl quinazoline derivative represented by the formula I for the preparation of a medicament with antitumor activity, especially against leukemias, intestinal or brain tumors.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436747A PL242765B1 (en) | 2021-01-25 | 2021-01-25 | 1,3-benzodioxole-5-sulfonyl quinazoline derivative for use in the treatment of cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL436747A PL242765B1 (en) | 2021-01-25 | 2021-01-25 | 1,3-benzodioxole-5-sulfonyl quinazoline derivative for use in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL436747A1 true PL436747A1 (en) | 2022-08-01 |
| PL242765B1 PL242765B1 (en) | 2023-04-17 |
Family
ID=83721734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL436747A PL242765B1 (en) | 2021-01-25 | 2021-01-25 | 1,3-benzodioxole-5-sulfonyl quinazoline derivative for use in the treatment of cancer |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL242765B1 (en) |
-
2021
- 2021-01-25 PL PL436747A patent/PL242765B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL242765B1 (en) | 2023-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202300924B (en) | Quinoxaline derivatives as anti-cancer drugs | |
| CY1123353T1 (en) | NOVEL CONDUCTED PYRIMIDINE COMPOUND OR SALT THEREOF | |
| GEAP202215535A (en) | Compounds | |
| CL2024000067A1 (en) | Antiviral compounds | |
| GEAP202215475A (en) | 2-amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors | |
| DOP2021000017A (en) | PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO PREVENT OR TREAT CANCERS INCLUDING THE SAME | |
| PH12018500437B1 (en) | Novel pyrazolo [3,4-d] pyrimidine compounds or salt thereof | |
| CR10056A (en) | [(1H-INDOL-5-IL) -HETEROARILOXI] - (1-AZA-BICICLO [3.3.1] NONANS AS N-ACHR COLLINERIC LIGANDS FOR THE TREATMENT OF PISCOTIC AND NEURODEGENERATIVE DISORDERS | |
| MX2022004451A (en) | HETEROARYL-BIPHENYL-AMIDES FOR THE TREATMENT OF DISEASES RELATED TO THE PD-L1 LIGAND. | |
| NZ735575A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
| GEP20196954B (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
| NI201000145A (en) | DERIVATIVES OF IMIDAZINE - [1, 2-b] - PYRIDAZINE FOR THE TREATMENT OF DISEASE MEDIATED BY TYROSINE KINASE C-MET. | |
| BR112019006047A2 (en) | compounds, one or two or more compounds, pharmaceutically acceptable salt, methanesulfonate salt, ret kinase inhibitor, medicament, uses of the compound and a compound, methods for treating or preventing cancer and for treating or preventing cancer in an individual, and, composition pharmaceutical | |
| ECSP099322A (en) | CHEMICAL COMPOUNDS | |
| CY1111203T1 (en) | 4-ANILINOKINOLINO-3-CARBOXAMIDE AS MOVEMENT INHIBITORS CSF-1R | |
| SA519402180B1 (en) | Novel Heterocyclic Compound, its Preparation Method, and Pharmaceutical Composition Comprising The Same | |
| PH12021500034A1 (en) | Compounds useful in hiv therapy | |
| MD20160016A2 (en) | New indolizine compounds, process for making them and pharmaceutical compositions containing them | |
| MX390835B (en) | HIGH SURFACE AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS | |
| BR112022009805A2 (en) | PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS | |
| CL2021002480A1 (en) | Macrocyclic compound agonists such as Sting's | |
| EA201490630A1 (en) | 6-SUBSTITUTED 3- (QUINOLIN-6-ILTIO) [1,2,4] TRIAZOLO [4,3-A] Pyridine as inhibitors of C-MET THYROZINKINASE | |
| MX2025002790A (en) | 2-substituted piperidine derivatives, preparation methods and medicinal uses thereof | |
| MX2023014131A (en) | 7-nitro-8-hydroxyquinoline derivative, preparation method therefor and medical use thereof. | |
| EA202092361A1 (en) | CONJUGATE OF A CYTOTOXIC DRUG AND PRODrug FORM OF THE SPECIFIED CONJUGATE |